Work

Abstract 4350: pH-responsive PEGylated antibodies enables tumor-specific activation and attenuates immune-related adverse events

Year: 2026
Type: conference-abstract
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7148860084
Cites:
Cited by:
Related to: